P-12, r. 6 - Regulation respecting the medications that a podiatrist who obtained a permit to practise before 1976 may administer or prescribe

Full text
SCHEDULE I
(ss. 1 and 2)
1. Any medication listed below, subject to the restrictions indicated:
MedicationsRestrictions
Aluminium and its salts 
Amcinonide 
Anthralin 
Silver sulfadiazine 
Bacitracin and its salts 
Beclomethasone and its salts 
Benzalkonium 
Benzocaine 
Betamethasone dipropionate 
Betamethasone valerate 
Bupivacaine and its saltsPharmaceutical form intended for administration by injection for local use only
Calcipotriol 
Calcitriol 
Camphor 
Cantharidin 
Cetirizine hydrochloride 
Chlorhexidine and its salts 
Ciclopirox olamine 
Cinchocaine (dibucaine) 
Clioquinol 
Clobetasol proprionate 
Clotrimazole 
Cyproheptadine hydrochloride 
Desonide 
Desoximetasone 
DiphenhydraminePharmaceutical form intended for oral and topical administration
Efinaconazole 
Epinephrine (adrenaline) 
ErythromycinPowder extemporaneous mixture or topical preparation
Ethyl chloride 
Fluocinolone acetonide 
Fluocinode 
Formalin 
Framycetin sulfate 
Fusidic acid 
Gentamicin sulfate 
Mineral tar 
Vegetal tar 
Gramicidin 
Hexachlorophene 
Hydrocortisone and its saltsPharmaceutical form intended for topical administration
Hydroxyzine hydrochloridePharmaceutical form intended for oral administration
Povidone iodine 
KetoconazolePharmaceutical form intended for topical administration
Lactic acid 
Lidocaine and its saltsPharmaceutical form intended for administration by injection for local use only
LoratadinePharmaceutical form intended for oral administration
LorazepamPharmaceutical form intended for oral and sublingual administration
Quantity limited to 4 tablets
MepivacainePharmaceutical form intended for administration by injection for local use only
Methylpolysiloxanes (dimethicone) 
Methylprednisolone acetate 
Miconazole nitrate 
Mometasone furorate 
Mupirocin 
Neomycin sulfate 
Nystatin, its salts and derivativesPharmaceutical form intended for topical administration
Dressings and products associated with the treatment of wounds and alterations of the skin and teguments 
Phenol 
Podophyllin 
Polymyxin B sulfate 
Pramoxine 
Promethazine hydrochloride 
Resorcinol and its salts 
Triethanolamine salicylate 
Salicylic acid 
Silicone (dimethicone) 
Sulphur colloidal 
Sulphur precipitate 
Sulphur sublimate 
Tazarotene 
Tolnaftate 
Triamcinolone acetonidePharmaceutical form intended for topical administration
Trichloroacetic acid 
Trimeprazine tartrate 
UreaPharmaceutical form intended for topical administration, with a concentration of 40% or less
2. Any other medication intended for topical or oral administration that is not listed in Schedule I of the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12).
3. Any combination of medications of this Schedule, subject to the applicable restrictions.
O.C. 1057-91, Sch. I; O.C. 142-2003, s. 3; O.C. 522-2005, s. 1; 173-2020O.C. 173-2020, s. 3.
SCHEDULE I
NOTE : Medications without specification are intended for topical application.

________________________________________________________________

Substances Specification
________________________________________________________________

Acetaminophen Pharmaceutical forms intended
for oral and rectal
administration

Acetic, glacial acid

Acetylsalicylic, Pharmaceutical forms intended
for oral administration

Aluminium and its salts

Almond, sweet oil

Amino acids

Amcinonide Quantity limited for 30 days

Anthralin (dithranol)

Silver nitrate

Silver sulfadiazine

Colloidal oatmeal

Bacitracin and its salts

Beclomethasone and its salts

Benzalkonium

Benzocaine

Betamethasone benzoate

Betamethasone Quantity limited for 30 days
dipropionate

Betamethasone valerate

Bupivacaine and Pharmaceutical forms intended
its salts for administration by injection
for local use only

Calcipotriol

Calcium acetate

Camphor

Cantharin

Capsaicin

Cetrimide

Cetirizine Pharmaceutical form intended
hydrochloride for oral administration

Chlorhexidine and its salts

Chlorphenesin

Chlorprocaine Pharmaceutical form intended
hydrochloride for administration by injection
for local use only

Ciclopirox olamine

Cinchocaine

Clioquinol
(iodochlorhydroxyquin)

Clobetasol Quantity limited for 30 days
proprionate

Clobetasone butyrate

Clotrimazole

Collagenase

Dakin’s solution

Desonide

Desoximetasone Quantity limited for 30 days

Deoxyribonuclease

Dichloracetic acid

Diflucortolone Quantity limited for 30 days
valerate

Diphenhydramine Pharmaceutical forms intended
for oral and topical
administration

Econazole nitrate

Epinephrine Pharmaceutical forms for the
(adrenaline) emergency treatment of
anaphylactic reactions in
the form of self-injector or
vial

Pharmaceutical form associated
with local anaesthetics

Erythromycin

Ethyl chloride

Fibrinolysin

Flumetasone pivalate

Fluocinolone Quantity limited for 30 days
acetonide

Fluocinode Quantity limited for 30 days

Formalin

Framycetin sulfate

Fusidic acid

Gentamicin sulfate

Gentian, violet

Mineral and vegetal tar

Gramicidin

Halcinodide Quantity limited for 30 days

Hexachlorophene

Mineral oil

Hydrocortisone and its salts

Hydroxyzine Pharmaceutical form intended
hydrochloride for oral administration

Povidone iodine

Iodine tincture

Isopropyl myristate

Ketoconazole

Lactic acid

Lanolin

Lidocaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only

Loratadine Pharmaceutical form intended
for oral administration

Lorazepam Pharmaceutical form intended
for oral and sublingual
administration in anticipation
of surgical procedures,
containing 0.5 mg or 1 mg
of Lorazepam per tablet

Quantity limited to 4 tablets

Mafenide and its salts

Menthol

Mepivacaine Pharmaceutical form intended
for administration by injection
for local use only

Methylpolysiloxanes

Methylprednisolone acetate

Miconazole nitrate

Mometasone furorate

Mupirocin

Neomycin sulfate

Nystatin

Oxiconazole

Phenol

Podophyllin

Polymyxin B sulfate

Pramoxine

Prilocaine Pharmaceutical forms intended
for topical application and
administration by injection
for local use only

Procaine Pharmaceutical form intended
for administration by injection
for local use only

Resorcinol and its salts

Diethylamine salicylate

Magnesium salicylate

Methyl salicylate

Triethanolamine salicylate

Salicylic acid

Synthetic sebum

Silicone

Sodium thiosulfate

Sulphur, colloidal,
precipitate or sublimate

Tazarotene

Terbinafine

Tetracaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only

Tioconazole

Tolnaftate

Triamcinolone Quantity limited for 30 days
acetonide

Trichloroacetic acid

Urea Pharmaceutical form intended
for topical application, with
a concentration of 30% or less

White petroleum jelly

Zinc oxide
O.C. 1057-91, Sch. I; O.C. 142-2003, s. 3; O.C. 522-2005, s. 1.